AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionArmstrong, Fleming & Moore, Inc
Latest Disclosed Ownership3,207 shares
Latest Disclosed Value $ 697,490
Armstrong, Fleming & Moore, Inc reports 14.25% increase in ownership of 4AB / AbbVie Inc.

On April 13, 2026 - Armstrong, Fleming & Moore, Inc filed a 13F-HR form disclosing ownership of 3,207 shares of AbbVie Inc. (BG:4AB) valued at $697,490 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 2,807 shares of AbbVie Inc.. This represents a change in shares of 14.25% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F ABBVIE COM 00287Y109 3,207 400 14.25 697 8.74 0.2961
2026-01-16 2025-12-31 13F ABBVIE COM 00287Y109 2,807 -178 -5.96 641 -7.24 0.2963
2025-10-20 2025-09-30 13F ABBVIE COM 00287Y109 2,985 0 0.00 691 24.73 0.3302
2025-07-23 2025-06-30 13F ABBVIE COM 00287Y109 2,985 411 15.97 554 2.78 0.3009
2025-04-11 2025-03-31 13F ABBVIE COM 00287Y109 2,574 -161 -5.89 539 10.91 0.6528
2025-02-05 2024-12-31 13F ABBVIE COM 00287Y109 2,735 0 0.00 486 -10.00 0.2945
2024-10-16 2024-09-30 13F ABBVIE COM 00287Y109 2,735 -432 -13.64 540 -0.55 0.3149
2024-07-23 2024-06-30 13F ABBVIE COM 00287Y109 3,167 4 0.13 543 -5.73 0.3484
2024-04-23 2024-03-31 13F ABBVIE COM 00287Y109 3,163 4 0.13 576 17.79 0.3987
2024-02-06 2023-12-31 13F ABBVIE COM 00287Y109 3,159 4 0.13 490 4.04 0.3690
2023-11-03 2023-09-30 13F ABBVIE COM 00287Y109 3,155 -46 -1.44 470 9.05 0.4559
2023-08-16 2023-06-30 13F ABBVIE COM 00287Y109 3,201 3,201 431 0.3967
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.